The transcription factor C/EBPβ in the dorsal root ganglion contributes to peripheral nerve trauma-induced nociceptive hypersensitivity

• Published in: Science signaling Vol. 10; no. 487
• Main Authors: Li, Zhisong, Mao, Yuanyuan, Liang, Lingli, Wu, Shaogen, Yuan, Jingjing, Mo, Kai, Cai, Weihua, Mao, Qingxiang, Cao, Jing, Bekker, Alex, Zhang, Wei, Tao, Yuan-Xiang
• Format: Journal Article
• Language: English
• Published: United States 11.07.2017
• Subjects: Animals; CCAAT-Enhancer-Binding Protein-beta - metabolism; Ganglia, Spinal - metabolism; Ganglia, Spinal - pathology; Histone-Lysine N-Methyltransferase - biosynthesis; Hyperalgesia - metabolism; Hyperalgesia - pathology; Ion Channel Gating; Kv1.2 Potassium Channel - biosynthesis; Male; Mice; Neuralgia - metabolism; Neuralgia - pathology; Peripheral Nerve Injuries - metabolism; Peripheral Nerve Injuries - pathology; Transcription, Genetic
• ISSN: 1937-9145
• DOI: 10.1126/scisignal.aam5345

Changes in gene transcription in the dorsal root ganglion (DRG) after nerve trauma contribute to the genesis of neuropathic pain. We report that peripheral nerve trauma caused by chronic constriction injury (CCI) increased the abundance of the transcription factor C/EBPβ (CCAAT/enhancer binding protein β) in the DRG. Blocking this increase mitigated the development and maintenance of CCI-induced mechanical, thermal, and cold pain hypersensitivities without affecting basal responses to acute pain and locomotor activity. Conversely, mimicking this increase produced hypersensitivity to mechanical, thermal, or cold pain. In the ipsilateral DRG, C/EBPβ promoted a decrease in the abundance of the voltage-gated potassium channel subunit Kv1.2 and μ opioid receptor (MOR) at the mRNA and protein levels, which would be predicted to increase excitability in the ipsilateral DRG neurons and reduce the efficacy of morphine analgesia. These effects required C/EPBβ-mediated transcriptional activation of (euchromatic histone-lysine -methyltransferase 2), which encodes G9a, an epigenetic silencer of the genes encoding Kv1.2 and MOR. Blocking the increase in C/EBPβ in the DRG improved morphine analgesia after CCI. These results suggest that C/EBPβ is an endogenous initiator of neuropathic pain and could be a potential target for the prevention and treatment of this disorder.